Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dolz, C.
Right arrow Articles by Gassull, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dolz, C.
Right arrow Articles by Gassull, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Changes in Liver Function Tests in Patients with Inflammatory Bowel Disease on Enteral Nutrition

Carles Dolz

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Xavier Xiol

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Agueda Abad

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Eduard Cabré

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Ferrán González-Huix

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Josep J. Giné

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Miquel A. Gassull

Department of Gastroenterology, Hospital de Bellvitge 'Princeps d'Espanya'. L'Hospitalet de Llobregat. Barcelona. Catalunya. Spain

Morphologic and functional hepatic changes occur in inflammatory bowel disease (IBD). Patients with this disease often require the administration of artificial nutritional support. Liver function tests (LFT) derangement is a widely recognized side-effect of total parenteral nutrition (TPN). Therefore, the use of this modality of nutritional support may be an additional factor to cause hepatic damage in IBD patients. However whether or not the same occurs in patients receiving total enteral nutrition (TEN) is not well-established. The aim of the present study was to evaluate the effect of TEN upon LFT in patients with moderate to severe acute attacks of IBD, by means of a prospective, controlled, and nonrandomized design. Forty-nine patients were included; 29 (11 patients with ulcerative colitis and 18 with Crohn's disease) received TEN, and 20 (11 with ulcerative colitis and 9 with Crohn's disease) did not. Both groups were homogeneous regarding age, sex, disease activity index, nutritional status, and length of the study (24.8 ± 1.3 vs 23.9 ± 16.8 days). In all cases, weekly measurements of serum alkaline phosphatase, GOT, and GPT were performed. There were no significant differences in LFT at the beginning of the study between groups. The percentage of patients showing derangement of some LFT during the study did not differ between both groups: six of 29 (20.6%) in TEN group vs three of 20 (15%) in control group. Six out of the nine patients (in both groups) who developed LFT derangement had one or more causes, other than TEN for explaining hepatic dysfunction. Only in three patients (one in the control group and two in the TEN group) could no other cause, apart from TEN and/or IBD itself, be found to explain the impairment in LFT. Nevertheless, this was mild and did not require either the performance of liver biopsy or the suppression of TEN. These results suggest that, in contrast to TPN, TEN does not imply an additional risk for liver damage in IBD patients. Therefore, TEN can only be blamed for producing LFT derangement when other causes linked to IBD, its complications, and its treatment have been carefully ruled-out. (Journal of Parenteral and Enteral Nutrition 13:401-405, 1989)

Journal of Parenteral and Enteral Nutrition, Vol. 13, No. 4, 401-405 (1989)
DOI: 10.1177/0148607189013004401


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
A. Abad-Lacruz, F. Gonzalez-Huix, M. Esteve, F. Fernandez-Banares, E. Cabre, J. Boix, D. Acero, P. Humbert, and M. A. Gassull
Liver Function Tests Abnormalities in Patients with Inflammatory Bowel Disease Receiving Artificial Nutrition: A Prospective Randomized Study of Total Enteral Nutrition vs Total Parenteral Nutrition
JPEN J Parenter Enteral Nutr, November 1, 1990; 14(6): 618 - 621.
[Abstract] [PDF]